Suppr超能文献

一名造血干细胞移植后患有出血性膀胱炎的患者长期使用非那吡啶后出现海因茨小体溶血:新一代面临的老问题。

Heinz body hemolysis following extended use phenazopyridine in a post-HCT patient with hemorrhagic cystitis: An old problem for a new generation.

作者信息

Ferdjallah Asmaa, Long Susie, Dayton Vanessa, Gupta Ashish O

机构信息

Division of Blood and Marrow Transplant and Cellular Therapy, Department of Pediatrics University of Minnesota Minneapolis Minnesota USA.

MHealth Fairview, Acute Care Pharmacy Services Minneapolis Minnesota USA.

出版信息

Clin Case Rep. 2023 Mar 7;11(3):e7012. doi: 10.1002/ccr3.7012. eCollection 2023 Mar.

Abstract

Hemorrhagic cystitis is a common complication following the use of cyclophosphamide. Associated dysuria can be painful and there are few good options to relieve pain. Phenazopyridine has historically been utilized for dysuria and is available over the counter. However, it is associated with hematologic side effects with prolonged use. Here we present a case of a patient who developed Heinz body hemolysis following prolonged administration of phenazopyridine to treat cyclophosphamide-induced hemorrhagic cystitis following hematopoietic stem cell transplant.

摘要

出血性膀胱炎是使用环磷酰胺后的一种常见并发症。相关的排尿困难会很痛苦,而且缓解疼痛的好方法很少。非那吡啶历来被用于治疗排尿困难,且可在柜台购买。然而,长期使用会导致血液学副作用。在此,我们报告一例患者,在造血干细胞移植后因长期服用非那吡啶治疗环磷酰胺诱导的出血性膀胱炎而发生海因茨小体溶血。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a8f/9992140/ccd4e4e79abc/CCR3-11-e7012-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验